SCHEMBL23957007

SCHEMBL23957007

CCN(CC)CCNC(=O)c1sc(-c2cccc(C#N)c2)nc1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 3/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ KMT2A Q03164 3/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ ALDH1A1 P00352 3/20 0.45
▸ MAPT P10636 3/20 0.45
▸ GAA P10253 1/20 0.45
▸ TP53 P04637 2/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ GFER P55789 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ RAD52 P43351 1/20 0.41
▸ CAMK2D Q13557 1/20 0.41
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ MCHR1 Q99705 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ PPARA Q07869 1/20 0.40
▸ EGLN1 Q9GZT9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23957002 0.83 NPC1 (0.45) HPGDNPC1KMT2AMEN1SMN1; SMN2
Hydrochloric Acid SCHEMBL29217420 0.83 XDH (0.44) HPGDNPC1KMT2AMEN1SMN1; SMN2
SCHEMBL25828324 0.80 XDH (0.54) HPGDNPC1KMT2AMEN1MAPT
SCHEMBL3399977 0.80 TSHR (0.53) HPGDNPC1KMT2AMEN1SMN1; SMN2
SCHEMBL3401375 0.79 SMYD2 (0.51) HPGDNPC1SMN1; SMN2GAATP53
SCHEMBL23956927 0.79 CD274 (0.52) HPGDKMT2AALDH1A1MAPTCYP1A2
SCHEMBL25828169 0.78 XDH (0.69) —
SCHEMBL3396720 0.78 MAPT (0.56) HPGDNPC1KMT2AMEN1SMN1; SMN2
Hydrochloric Acid SCHEMBL29217433 0.77 XDH (0.68) —
SCHEMBL3403000 0.76 NPC1 (0.50) HPGDNPC1KMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021215624-A1 NOVEL 2-ARYLTHIAZOLE DERIVATIVE OR SALT THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME (주)헥사파마텍 (KR) 2021-10-28 — — WO disclosed
Send feedback